FDA approves new generic for valsartan

After multiple recalls of a certain generic valsartan medications, the U.S. Food and Drug Administration has approved a new generic of the blood pressure medication to help alleviate the recent shortage due to the recalls. Recalls have only involved generics of the drug, not the brand name Diovan. Click here for more details.

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.